10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-121786`
Period End Date	20200930
Filing Date	20201105
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	cldx-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 65 Cash Flow Statement 64

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.15M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.59M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$181.44M	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$53.15M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.01M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$838.00K	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.30M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.49M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$202.93M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	39.56M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	16.97M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$66.70M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	39.56M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	16.97M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$3.81M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$4.03M	USD	Point-in-time
Operating Lease Right-of-Use Assets, Net	`OperatingLeaseRightOfUseAsset`	$3.80M	USD	Point-in-time
Operating Lease Right-of-Use Assets, Net	`OperatingLeaseRightOfUseAsset`	$3.47M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$45.19M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$48.69M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Total Assets	`Assets`	$122.93M	USD	Point-in-time
Total Assets	`Assets`	$255.77M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.17M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$568.00K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$6.50M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$8.01M	USD	Point-in-time
Current Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityCurrent`	$1.26M	USD	Point-in-time
Current Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityCurrent`	$1.94M	USD	Point-in-time
Current Portion of Other Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.36M	USD	Point-in-time
Current Portion of Other Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.03M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$12.20M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.64M	USD	Point-in-time
Long-Term Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.71M	USD	Point-in-time
Long-Term Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.54M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$15.55M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$11.05M	USD	Point-in-time
Total Liabilities	`Liabilities`	$28.91M	USD	Point-in-time
Total Liabilities	`Liabilities`	$25.80M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 39,562,472 and 16,972,077 Shares Issued and Outstanding at September 30, 2020 and December 31, 2019, Respectively	`CommonStockValue`	$40.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 39,562,472 and 16,972,077 Shares Issued and Outstanding at September 30, 2020 and December 31, 2019, Respectively	`CommonStockValue`	$17.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.28B	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.10B	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.61M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.62M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-1.05B	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$229.97M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$94.03M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$124.06M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$238.44M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$112.69M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$83.70M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$109.63M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$101.38M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$255.77M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$122.93M	USD	Point-in-time

Income Statement 65 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$546.00K	USD	1 Quarter
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.63M	USD	3 Qtrs
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.69M	USD	3 Qtrs
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$668.00K	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$32.11M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$10.71M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$11.10M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$32.33M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$3.64M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$3.40M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$12.21M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$10.83M	USD	3 Qtrs
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	1 Quarter
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	3 Qtrs
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	3 Qtrs
Loss (Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.61M	USD	3 Qtrs
Loss (Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-662.00K	USD	1 Quarter
Loss (Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$2.11M	USD	1 Quarter
Loss (Gain) on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.24M	USD	3 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$42.21M	USD	3 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$15.01M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$12.39M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$44.73M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-11.84M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-14.34M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-38.57M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-42.04M	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$465.00K	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.61M	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$431.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$118.00K	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.41M	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.43M	USD	3 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-14.22M	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-38.11M	USD	3 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	3 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-200.00K	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.41M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-14.22M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-37.88M	USD	3 Qtrs
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-40.43M	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-0.75	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-0.36	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-2.92	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-1.44	USD	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.28M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.85M	shares	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.28M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss Per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.30M	shares	3 Qtrs
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.41M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-14.22M	USD	1 Quarter
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-37.88M	USD	3 Qtrs
Net Loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-40.43M	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-11.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$19.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-22.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$52.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-40.38M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.42M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-14.21M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-37.89M	USD	3 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.03M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.41M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-40.43M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.78M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-37.88M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-14.22M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$3.71M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$3.17M	USD	3 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$980.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$422.00K	USD	3 Qtrs
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$29.00K	USD	3 Qtrs
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-7.00K	USD	3 Qtrs
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	1 Quarter
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	3 Qtrs
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	3 Qtrs
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.61M	USD	3 Qtrs
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-662.00K	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$2.11M	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.24M	USD	3 Qtrs
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	3 Qtrs
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-200.00K	USD	1 Quarter
Stock-Based Compensation Expense	`ShareBasedCompensation`	$3.86M	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$2.66M	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-177.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-2.44M	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-208.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.28M	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-884.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$864.00K	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.49M	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-3.54M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-35.19M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-35.41M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$91.47M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$55.60M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$77.01M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$183.39M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.30M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$626.00K	USD	3 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$20.00K	USD	3 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$29.00K	USD	3 Qtrs
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$13.86M	USD	3 Qtrs
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-129.07M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$170.96M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$13.83M	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$9.00K	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$218.00K	USD	3 Qtrs
Issuance of Term Loan	`ProceedsFromIssuanceOfDebt`	$2.96M	USD	3 Qtrs
Payment of Term Loan	`RepaymentsOfDebt`	$2.96M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$171.18M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$13.84M	USD	3 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.92M	USD	3 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.72M	USD	3 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.15M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$16.59M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.15M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$16.59M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$63.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.